东曜药业-B
港股通 官网
( 01875.hk)
市盈率167.79市净率1.88市销率1.37股息率0.00%上市时间2019-11-08股价1.89港币 (8.62% , 3,000.00港币) 市值14.61亿港币总股本7.73亿上市至今年化投资收益率-20.73%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
备注 (1): 双击编辑备注
发表讨论

东曜药业-B(01875) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1劉衛東Non Executive Director2023-08-12--
2黃純瑩Non Executive Director2023-01-01--
3汪德潛Independent Non Executive Director2022-03-12--
4張鴻仁Independent Non Executive Director2019-03-12--
5胡蘭Independent Non Executive Director2019-03-12--
6孫利軍Independent Non Executive Director2019-03-122022-03-12
7劉軍Executive DirectorCEO2018-10-26--
8裘育敏Non Executive Director2018-09-262023-08-12
9付山Non Executive DirectorChairman2016-01-19--
10黃純瑩Executive Director2016-01-192023-01-01
11孔繁建Non Executive Director2016-01-192022-03-12
12康霈Non Executive Director2011-01-112022-03-12